Atlas Trials

Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndromes and Acute Myeloid Leukemia

Clinical trial NCT00671697 · COMPLETED

Trial details

NCT number
NCT00671697
Sponsor
Washington University School of Medicine
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Myelodysplastic Syndromes and Leukemia, Myeloid, Acute
Start date
2008-05-01
Primary completion
2010-01-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.